The results of this study, presented very recently in abstract form, indicate that resmetirom treatment 80 mg, and 100 mg compared to placebo resulted in highly significant increase in NASH resolution 26%, 30% vs. 10%, and reduction in NAFLD activity score 24%, 26% versus 14%, respectively.
1
—
—